Gilead Sciences (GILD) Total Liabilities (2009 - 2026)
Gilead Sciences posted quarterly Total Liabilities of $32.8 billion for Q1 2026, down 12.3% year-on-year from $37.4 billion in Q1 2025, and down 9.79% on a QoQ basis from $36.3 billion in Q4 2025.
Gilead Sciences (GILD) has 18 years of Total Liabilities data on file, last reported at $32.8 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 12.3% year-over-year to $32.8 billion; the trailing twelve-month figure through Mar 2026 stood at $32.8 billion (down 12.3% YoY), and the FY2025 full-year result was $36.3 billion, down 8.63% from the prior year.
- Total Liabilities for Q1 2026 stood at $32.8 billion, down from $36.3 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $43.2 billion in Q1 2022 and bottomed at $32.8 billion in Q1 2026.
- The 5-year median for Total Liabilities is $39.4 billion (2023), against an average of $38.9 billion.
- The widest annual swing landed in 2024, when Total Liabilities decreased 14.21%; it then increased 2.37% in 2025.
- A 5-year view of Total Liabilities shows it stood at $42.0 billion in 2022, then slipped by 6.16% to $39.4 billion in 2023, then climbed by 0.95% to $39.7 billion in 2024, then decreased by 8.63% to $36.3 billion in 2025, then decreased by 9.79% to $32.8 billion in 2026.
- The last three Total Liabilities figures came in at $32.8 billion (Q1 2026), $36.3 billion (Q4 2025), and $37.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 85.38 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 119.71 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 143.08 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 82.75 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 83.31 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 32.76 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 117.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 66.37 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 60.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.76 Bn |
| Dec 31, 2025 | 36.32 Bn |
| Sep 30, 2025 | 36.99 Bn |
| Jun 30, 2025 | 36.13 Bn |
| Mar 31, 2025 | 37.36 Bn |
| Dec 31, 2024 | 39.75 Bn |
| Sep 30, 2024 | 36.14 Bn |
| Jun 30, 2024 | 35.38 Bn |
| Mar 31, 2024 | 38.84 Bn |
| Dec 31, 2023 | 39.38 Bn |
| Sep 30, 2023 | 40.13 Bn |
| Jun 30, 2023 | 41.24 Bn |
| Mar 31, 2023 | 40.94 Bn |
| Dec 31, 2022 | 41.96 Bn |
| Sep 30, 2022 | 41.50 Bn |
| Jun 30, 2022 | 42.66 Bn |
| Mar 31, 2022 | 43.17 Bn |
| Dec 31, 2021 | 46.89 Bn |
| Sep 30, 2021 | 45.63 Bn |
| Jun 30, 2021 | 48.27 Bn |
| Mar 31, 2021 | 48.53 Bn |
| Dec 31, 2020 | 50.19 Bn |
| Sep 30, 2020 | 43.41 Bn |
| Jun 30, 2020 | 37.79 Bn |
| Mar 31, 2020 | 37.56 Bn |
| Dec 31, 2019 | 38.98 Bn |
| Sep 30, 2019 | 38.41 Bn |
| Jun 30, 2019 | 40.46 Bn |
| Mar 31, 2019 | 40.75 Bn |
| Dec 31, 2018 | 42.14 Bn |
| Sep 30, 2018 | 41.30 Bn |
| Jun 30, 2018 | 43.62 Bn |
| Mar 31, 2018 | 44.73 Bn |
| Dec 31, 2017 | 49.78 Bn |
| Sep 30, 2017 | 39.82 Bn |
| Jun 30, 2017 | 37.17 Bn |
| Mar 31, 2017 | 36.78 Bn |
| Dec 31, 2016 | 37.61 Bn |
| Sep 30, 2016 | 39.74 Bn |
| Jun 30, 2016 | 33.87 Bn |
| Mar 31, 2016 | 33.75 Bn |
| Dec 31, 2015 | 32.60 Bn |
| Sep 30, 2015 | 32.69 Bn |
| Jun 30, 2015 | 22.53 Bn |
| Mar 31, 2015 | 21.14 Bn |
| Dec 31, 2014 | 18.85 Bn |
| Sep 30, 2014 | 14.98 Bn |
| Jun 30, 2014 | 14.78 Bn |
| Mar 31, 2014 | 14.69 Bn |
| Dec 31, 2013 | 10.83 Bn |
| Sep 30, 2013 | 11.28 Bn |
| Jun 30, 2013 | 11.53 Bn |
| Mar 31, 2013 | 11.82 Bn |
| Dec 31, 2012 | 11.70 Bn |
| Sep 30, 2012 | 12.36 Bn |
| Jun 30, 2012 | 12.42 Bn |
| Mar 31, 2012 | 12.64 Bn |
| Dec 31, 2011 | 10.44 Bn |
| Sep 30, 2011 | 6.52 Bn |
| Jun 30, 2011 | 6.48 Bn |
| Mar 31, 2011 | 6.81 Bn |
| Dec 31, 2010 | 5.47 Bn |
| Sep 30, 2010 | 5.58 Bn |
| Mar 31, 2010 | 3.19 Bn |
| Dec 31, 2009 | 3.19 Bn |
| Sep 30, 2009 | 3.29 Bn |
| Jun 30, 2009 | 3.07 Bn |